Poliovirus Therapy for Recurrent Glioblastoma Has Three-Year Survival Rate of 21 Percent
Published
Written By
Sarah Avery
Director, Duke Health News Office
Related News
Duke University School of Medicine
Duke Health Giving
Related News
Duke University School of Medicine
Duke Health Giving